However, in this analysis we found a higher risk of dyslipidemia in the co-dominant model of rs2854116 in the APOC3 in those carrying the CC genotype than in those carrying the TT genotype (OR  = 1.59, 95% CI 1.03–2.45), but the test did not reach a significant level. This evidence concerns the gene APOC3 and metabolic syndrome.